Skip to main content

Oral Therapy

shutterstock_2046335624
Rheumatologic Disorders

Xeljanz (tofacitinib) First Oral Therapy Approved for Ankylosing spondylitis (AS)

By Dr. David BorensteinJan 17, 2022